山竹醇药理作用研究进展
Research Progress on the Pharmacological Effects of Garcinol
DOI: 10.12677/acm.2026.1652135, PDF,    科研立项经费支持
作者: 权 泉, 黄曦醇, 李君豪, 宁 钊, 李红叶, 赵文慧, 金成浩*:黑龙江八一农垦大学生命科学技术学院,黑龙 江大庆
关键词: 山竹醇药理作用抗肿瘤抗炎神经保护Garcinol Pharmacological Effects Anti-Tumor Anti-Inflammatory Neuroprotective
摘要: 山竹醇是一种广泛存在于藤黄属植物果皮中的多聚异戊二烯基二苯甲酮类天然小分子化合物。该化合物具有良好的抗肿瘤、抗炎、神经保护、代谢调节及抗菌等多种药理作用,近年来备受中外学者关注。本文对山竹醇的药理作用及其分子机制进行综述,系统总结其在抗肿瘤、抗炎及神经保护方面的研究进展,以期为山竹醇的进一步开发与临床应用提供理论指导。
Abstract: Garcinol is a natural small-molecule compound of the polyisoprenylated benzophenone class, widely found in the peel of plants belonging to the Garcinia genus. This compound possesses a variety of pharmacological activities, including anti-tumor, anti-inflammatory, neuroprotective, metabolic regulatory, and antibacterial effects, which have attracted increasing attention from researchers worldwide. This article reviews the pharmacological effects and molecular mechanisms of garcinol, systematically summarizing the research progress in its anti-tumor, anti-inflammatory, and neuroprotective aspects, with the aim of providing theoretical guidance for the further development and clinical application of garcinol.
文章引用:权泉, 黄曦醇, 李君豪, 宁钊, 李红叶, 赵文慧, 金成浩. 山竹醇药理作用研究进展[J]. 临床医学进展, 2026, 16(5): 3167-3175. https://doi.org/10.12677/acm.2026.1652135

参考文献

[1] Saadat, N. and Gupta, S.V. (2012) Potential Role of Garcinol as an Anticancer Agent. Journal of Oncology, 2012, Article ID: 647206. [Google Scholar] [CrossRef] [PubMed]
[2] Padhye, S., Ahmad, A., Oswal, N. and Sarkar, F.H. (2009) Emerging Role of Garcinol, the Antioxidant Chalcone from Garcinia indica Choisy and Its Synthetic Analogs. Journal of Hematology & Oncology, 2, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
[3] Kopytko, P., Piotrowska, K., Janisiak, J. and Tarnowski, M. (2021) Garcinol—A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug. International Journal of Molecular Sciences, 22, Article 2828. [Google Scholar] [CrossRef] [PubMed]
[4] Sethi, G., Chatterjee, S., Rajendran, P., Li, F., Shanmugam, M.K., Wong, K.F., et al. (2014) Inhibition of STAT3 Dimerization and Acetylation by Garcinol Suppresses the Growth of Human Hepatocellular Carcinoma in Vitro and in Vivo. Molecular Cancer, 13, Article No. 66. [Google Scholar] [CrossRef] [PubMed]
[5] Li, F., Shanmugam, M.K., Chen, L., Chatterjee, S., Basha, J., Kumar, A.P., et al. (2013) Garcinol, a Polyisoprenylated Benzophenone Modulates Multiple Proinflammatory Signaling Cascades Leading to the Suppression of Growth and Survival of Head and Neck Carcinoma. Cancer Prevention Research, 6, 843-854. [Google Scholar] [CrossRef] [PubMed]
[6] Aggarwal, V., Tuli, H.S., Kaur, J., Aggarwal, D., Parashar, G., Chaturvedi Parashar, N., et al. (2020) Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells. Biomedicines, 8, Article 103. [Google Scholar] [CrossRef] [PubMed]
[7] Hsu, C., Lin, Y., Ho, C. and Yen, G. (2012) Inhibitory Effects of Garcinol and Pterostilbene on Cell Proliferation and Adipogenesis in 3T3-L1 Cells. Food & Function, 3, 49-57. [Google Scholar] [CrossRef] [PubMed]
[8] Aggarwal, S. and Das, S.N. (2016) Garcinol Inhibits Tumour Cell Proliferation, Angiogenesis, Cell Cycle Progression and Induces Apoptosis via NF-κB Inhibition in Oral Cancer. Tumor Biology, 37, 7175-7184. [Google Scholar] [CrossRef] [PubMed]
[9] Cheng, A., Tsai, M., Liu, C., Lee, M., Nagabhushanam, K., Ho, C., et al. (2010) Garcinol Inhibits Cell Growth in Hepatocellular Carcinoma Hep3B Cells through Induction of ROS-Dependent Apoptosis. Food & Function, 1, 301-307. [Google Scholar] [CrossRef] [PubMed]
[10] Parasramka, M. and Gupta, S. (2011) Garcinol Inhibits Cell Proliferation and Promotes Apoptosis in Pancreatic Adenocarcinoma Cells. Nutrition and Cancer, 63, 456-465. [Google Scholar] [CrossRef] [PubMed]
[11] Ahmad, A., Sarkar, S.H., Aboukameel, A., Ali, S., Biersack, B., Seibt, S., et al. (2012) Anticancer Action of Garcinol in Vitro and in Vivo Is in Part Mediated through Inhibition of STAT-3 Signaling. Carcinogenesis, 33, 2450-2456. [Google Scholar] [CrossRef] [PubMed]
[12] Rizvi, S.M.D., Almazni, I.A., Moawadh, M.S., Alharbi, Z.M., Helmi, N., Alqahtani, L.S., et al. (2024) Targeting NF-κB Signaling Cascades of Glioblastoma by a Natural Benzophenone, Garcinol, via in Vitro and Molecular Docking Approaches. Frontiers in Chemistry, 12, Article 1352009. [Google Scholar] [CrossRef] [PubMed]
[13] 喻颖, 柯细松, 张雪. 山竹醇靶向RPN6抑制蛋白酶体及抗肿瘤活性研究[J]. 药学学报, 2025, 60(2): 408-416.
[14] Wang, J., Wu, M., Zheng, D., Zhang, H., Lv, Y., Zhang, L., et al. (2020) Garcinol Inhibits Esophageal Cancer Metastasis by Suppressing the p300 and TGF-β1 Signaling Pathways. Acta Pharmacologica Sinica, 41, 82-92. [Google Scholar] [CrossRef] [PubMed]
[15] Ahmad, A., Sarkar, S.H., Bitar, B., Ali, S., Aboukameel, A., Sethi, S., et al. (2012) Garcinol Regulates EMT and Wnt Signaling Pathways in Vitro and in Vivo, Leading to Anticancer Activity against Breast Cancer Cells. Molecular Cancer Therapeutics, 11, 2193-2201. [Google Scholar] [CrossRef] [PubMed]
[16] Yu, S., Liao, C., Chien, M., Tsai, T., Lin, J. and Weng, M. (2014) Induction of P21Waf1/Cip1 by Garcinol via Downregulation of p38-MAPK Signaling in p53-Independent H1299 Lung Cancer. Journal of Agricultural and Food Chemistry, 62, 2085-2095. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, M., Lu, Q., Hou, H., Sun, D., Chen, M., Ning, F., et al. (2021) Garcinol Inhibits the Proliferation of Endometrial Cancer Cells by Inducing Cell Cycle Arrest. Oncology Reports, 45, 630-640. [Google Scholar] [CrossRef] [PubMed]
[18] Rangappa, S. (2025) Garcinol, a Natural Benzophenone Overcomes Radio and Chemoresistance by Targeting PI3K-PKB/AKT Pathway in Rhabdomyosarcoma Cells. Journal of Biomolecular Structure and Dynamics, 43, 10732-10737. [Google Scholar] [CrossRef
[19] Chantree, P., Martviset, P., Thongsepee, N., Sangpairoj, K. and Sornchuer, P. (2023) Anti-Inflammatory Effect of Garcinol Extracted from Garcinia dulcis via Modulating NF-κB Signaling Pathway. Nutrients, 15, Article 575. [Google Scholar] [CrossRef] [PubMed]
[20] Jia, Y., Pang, C., Zhao, K., Jiang, J., Zhang, T., Peng, J., et al. (2019) Garcinol Suppresses Il-1β-Induced Chondrocyte Inflammation and Osteoarthritis via Inhibition of the NF-κB Signaling Pathway. Inflammation, 42, 1754-1766. [Google Scholar] [CrossRef] [PubMed]
[21] 张顺利, 顾运涛, 陈荣, 等. 山竹醇通过NF-κB信号通路抑制IL-1β诱导的髓核细胞炎症和细胞外基质降解[J]. 局解手术学杂志, 2021, 30(3): 189-194.
[22] Hung, M., Bamodu, A.O. and Yeh, C. (2018) Abstract 10357: Garcinol Attenuates Nicotine-Induced Inflammatory Cytokine Production in Cardiomyocyte by Modulating the p38 MAPKs and NF-κB Signaling Pathway through the α7 Nicotinic Acetyl-Choline Receptor. Circulation, 138, A10357.
[23] Dai, B., Ding, X.T., Zhang, H.X., et al. (2025) Garcinol Promotes Recovery after Spinal Cord Injury in Mouse by Modulating Microglial Polarization via EGFR/PI3K/AKT Signaling. Spine, 51, E154-E166.
[24] Li, Z., Lin, K., Wang, Y., Mao, J., Yin, Y., Li, Z., et al. (2025) Garcinol Promotes Wound Healing in Diabetic Mice by Regulating Inflammation and NLRP3 Inflammasome-Mediated Pyroptosis via the PI3K/Akt/NF-κB Pathway. International Immunopharmacology, 151, Article ID: 114352. [Google Scholar] [CrossRef] [PubMed]
[25] Kalita, A. and Das, M. (2024) Aquaporins (AQPs) as a Marker in the Physiology of Inflammation and Its Interaction Studies with Garcinol. Inflammopharmacology, 32, 1575-1592. [Google Scholar] [CrossRef] [PubMed]
[26] Kandasamy, K., Narasimhamoorthi, S.P., Arulselvan, P. and Jaganathan, D. (2026) Protective Effects of the Natural Polyphenol Garcinol from Garcinia indica Mitigates Aluminium Chloride-Induced Alzheimer’s-Like Neurodegeneration in Drosophila melanogaster. 3 Biotech, 16, Article No. 154. [Google Scholar] [CrossRef
[27] Mishra, A., Sankar Satapathy, B., Gatadi, S., Vasavi, M., Kumar Sahu, P. and Nuthakki, V. (2025) Garcinol as a Promising Therapeutic Candidate for Alzheimer’s Disease: Integrated Computational and in Vitro Target Analysis. ChemistrySelect, 10, e01371. [Google Scholar] [CrossRef
[28] Chetia Phukan, B., Dutta, A., Deb, S., Saikia, R., Mazumder, M.K., Paul, R., et al. (2021) Garcinol Blocks Motor Behavioural Deficits by Providing Dopaminergic Neuroprotection in MPTP Mouse Model of Parkinson’s Disease: Involvement of Anti-Inflammatory Response. Experimental Brain Research, 240, 113-122. [Google Scholar] [CrossRef] [PubMed]
[29] Khairujjaman, M.M., Rajib, P,. Chetia, B.P., et al. (2018) Garcinol, an Effective Monoamine Oxidase-B Inhibitor for the Treatment of Parkinson’s Disease. Medical Hypotheses, 117, 54-58.
[30] Wang, Y., Zhang, X., Chen, C., Liu, Q., Xu, J., Qian, Q., et al. (2017) Protective Effects of Garcinol against Neuropathic Pain—Evidence from in Vivo and in Vitro Studies. Neuroscience Letters, 647, 85-90. [Google Scholar] [CrossRef] [PubMed]
[31] Sharma, C. and Kang, S.C. (2020) Garcinol Pacifies Acrylamide Induced Cognitive Impairments, Neuroinflammation and Neuronal Apoptosis by Modulating GSK Signaling and Activation of pCREB by Regulating Cathepsin B in the Brain of Zebrafish Larvae. Food and Chemical Toxicology, 138, Article ID: 111246. [Google Scholar] [CrossRef] [PubMed]
[32] Algefare, A.I. (2025) Effect of Garcinol against Arsenic-Induced Neurobehavioral Alterations and Liver and Kidney Dysfunction in Albino Mice. BioMedicine, 15, Article 4. [Google Scholar] [CrossRef
[33] Lee, P., Teng, C., Kalyanam, N., Ho, C. and Pan, M. (2019) Front Cover: Garcinol Reduces Obesity in High‐Fat-Diet‐Fed Mice by Modulating Gut Microbiota Composition. Molecular Nutrition & Food Research, 63, Article ID: 1970003. [Google Scholar] [CrossRef
[34] Majeed, M., Majeed, S., Nagabhushanam, K., Lawrence, L. and Mundkur, L. (2020) Garcinia indica Extract Standardized for 20% Garcinol Reduces Adipogenesis and High Fat Diet-Induced Obesity in Mice by Alleviating Endoplasmic Reticulum Stress. Journal of Functional Foods, 67, Article ID: 103863. [Google Scholar] [CrossRef
[35] Muhammed, M., Kalyanam, N., Mazen, N., et al. (2023) A Scientifically Validated Combination of Garcinol, Curcuminoids, and Piperine for Mild to Moderate Nonalcoholic Steatohepatitis Patients-Results from a Randomized, Double-Blind, Placebo-Controlled Study. Frontiers in Nutrition, 10, Article 1201186.
[36] Basumatary, D., Das, S., Bidyarani Devi, M., Shalini Devi, G., Sarma, P., Mukherjee, A.K., et al. (2024) Garcinol Enriched Fraction of Garcinia morella (Gaertn.) Desr. Fruit Rind Improves Gut Health and Reduces the Risk of Nonalcoholic Fatty Liver Disease by Regulating PCK1/ACC/SREBP1/FASn Pathway in a Mouse Model. Food Research International, 197, Article ID: 115285. [Google Scholar] [CrossRef] [PubMed]
[37] Madhuri, K. and Naik, P.R. (2017) Modulatory Effect of Garcinol in Streptozotocin-Induced Diabetic Wistar Rats. Archives of Physiology and Biochemistry, 123, 322-329. [Google Scholar] [CrossRef] [PubMed]
[38] Mali, K.K., Dias, R.J., Havaldar, V.D. and Yadav, S.J. (2017) Antidiabetic Effect of Garcinol on Streptozotocin-Induced Diabetic Rats. Indian Journal of Pharmaceutical Sciences, 79, 463-468. [Google Scholar] [CrossRef
[39] Patra, P.A., Palakkandi, D., Krishnegowda, A.K., Vijayarengan, M., Mutturi, S., Linganna, S., et al. (2025) Flash Chromatographic Isolation of Garcinol and Isogarcinol from Garcinia indica Choisy (Kokum) Fruit and Evaluation of Their Potential Antibiofilm Activity. Microbial Pathogenesis, 198, Article ID: 107127. [Google Scholar] [CrossRef] [PubMed]
[40] Chatterjee, A., Yasmin, T., Bagchi, D. and Stohs, S.J. (2003) The Bactericidal Effects of Lactobacillus acidophilus, Garcinol and Protykin® Compared to Clarithromycin, on Helicobacter pylori. Molecular and Cellular Biochemistry, 243, 29-35. [Google Scholar] [CrossRef] [PubMed]
[41] Corona, A., Seibt, S., Schaller, D., Schobert, R., Volkamer, A., Biersack, B., et al. (2021) Garcinol from Garcinia indica Inhibits HIV‐1 Reverse Transcriptase-Associated Ribonuclease H. Archiv der Pharmazie, 354, Article ID: 2100123. [Google Scholar] [CrossRef] [PubMed]
[42] Ganguly, S.C., Ganguly, S., Mahanti, B., Pal, P.C., Dutta, S. and Majumdar, S. (2025) Elucidating the Anti-Inflammatory Potential of Nanoscaled Polymeric-Albumin Blends of Garcinol: Optimization, in Silico, in Vitro, and in Vivo Studies. International Journal of Biological Macromolecules, 303, Article ID: 140469. [Google Scholar] [CrossRef] [PubMed]
[43] Gaonkar, R.H., Ganguly, S., Dewanjee, S., Sinha, S., Gupta, A., Ganguly, S., et al. (2017) Garcinol Loaded Vitamin E TPGS Emulsified PLGA Nanoparticles: Preparation, Physicochemical Characterization, in Vitro and in Vivo Studies. Scientific Reports, 7, Article No. 530. [Google Scholar] [CrossRef] [PubMed]
[44] Javvaji, K., Vangala, V., Deshpande, S.S., Matta, S., Kandimalla, R., Puvvada, N., et al. (2025) Targeted Liposome Garcinol Formulation for the Treatment of Colon Cancer: Pharmacological and Toxicological Evaluation. ACS Applied Bio Materials, 8, 8767-8783. [Google Scholar] [CrossRef
[45] Fazio, A., Briglia, M., Faggio, C., Alzoubi, K. and Lang, F. (2015) Stimulation of Suicidal Erythrocyte Death by Garcinol. Cellular Physiology and Biochemistry, 37, 805-815. [Google Scholar] [CrossRef] [PubMed]
[46] Wang, B., Lin, L., Ai, Q., Zeng, T., Ge, P. and Zhang, L. (2016) HAT Inhibitor, Garcinol, Exacerbates Lipopolysaccharide-Induced Inflammation in Vitro and in Vivo. Molecular Medicine Reports, 13, 5290-5296. [Google Scholar] [CrossRef] [PubMed]